Brief: ThermoGenesis Awarded NIH SBIR Phase I Grant
Sept 14 (Reuters) - Thermogenesis Holdings Inc THMO.O :
* THERMOGENESIS AWARDED NIH SBIR PHASE I GRANT TO DEVELOP
KEY CELL
PROCESSING DISPOSABLE FOR QUINTESSENCE AUTOMATED MANUFACTURING
OF GENE-ENGINEERED AUTOLOGOUS CELL (GEAC) THERAPIES
Source text for Eikon: ID:nPn1mNZBMa
Further company coverage: THMO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Thermogenesis Holdings
See all newsThermogenesis Holdings Inc expected to post earnings of 1 cent a share - Earnings Preview
Thermogenesis Holdings Inc reports results for the quarter ended in December - Earnings Summary
Thermogenesis Holdings Inc expected to post a loss of 1 cent a share - Earnings Preview
Thermogenesis Holdings Inc expected to post a loss of 1 cent a share - Earnings Preview
Brief: Thermogenesis Holdings Says On Jan 8 Co Received Nasdaq Letter Notifying It No Longer Complies With Minimum Bid Price Requirement For Listing On Nasdaq